{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:09:42Z","timestamp":1772446182609,"version":"3.50.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A 43-year-old man reported with upper respiratory tract symptoms and tested positive for coronavirus disease 2019 (COVID-19) antigens. The symptoms improved quickly, but 1\u00a0month later, myalgia in both shoulders and from both thighs to both lower legs, pharyngeal pain, and dyspnoea appeared. His muscle strength was low, and laboratory tests showed an elevated serum creatine kinase level at 1273\u00a0U\/l. A COVID-19 polymerase chain reaction test was positive on the day of admission, and a diagnosis of multisystem inflammatory syndrome in adults was considered. The patient received high-dose intravenous immunoglobulin (30\u00a0g for 5\u00a0days) for myositis due to multisystem inflammatory syndrome in adults with muscle weakness refractory to glucocorticoids, but progressive dysphagia led to a gradual reduction in the ability to swallow saliva. The patient choked due to sputum, resulting in cardiopulmonary arrest on Day 31. Lifesaving measures were immediately performed, and the patient\u2019s heartbeat resumed. However, on Day 39, the patient experienced a gastrointestinal perforation and underwent emergency surgery. Since antinuclear matrix protein 2 antibody-positive dermatomyositis (DM) is known as a severe form of DM that can cause gastrointestinal perforation, we measured the antibody and found it to be positive. We report the case of gastrointestinal perforation in a patient with antinuclear matrix protein 2 antibody-positive DM that developed after a COVID-19 infection and was successfully managed through multidisciplinary therapy.<\/jats:p>","DOI":"10.1093\/mrcr\/rxag012","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:48:27Z","timestamp":1770295707000},"source":"Crossref","is-referenced-by-count":0,"title":["Critical illness with fatal muscle weakness and gastrointestinal perforation after COVID-19"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8867-6236","authenticated-orcid":false,"given":"Kazutaka","family":"Kawamori","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa Medical University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2638-6032","authenticated-orcid":false,"given":"Tomoki","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa Medical University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1617-086X","authenticated-orcid":false,"given":"Takashi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-3962","authenticated-orcid":false,"given":"Nobuyuki","family":"Yajima","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa Medical University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"2026030204312286400_ref1","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1007\/s10067-021-05667-x","article-title":"Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody","volume":"40","author":"Yan","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2026030204312286400_ref2","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1007\/s10067-023-06751-0","article-title":"Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population","volume":"42","author":"Manwatkar","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2026030204312286400_ref3","first-page":"e935005","article-title":"Editorial: multisystem inflammatory syndrome in adults (MIS-A) and the spectrum of COVID-19","volume":"27","author":"Parums","year":"2017","journal-title":"Med Sci Monit"},{"key":"2026030204312286400_ref4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13052-024-01585-1","article-title":"New insight into the intravenous immunoglobulin treatment in multisystem inflammatory syndrome in children and adults","volume":"50","author":"Chen","year":"2024","journal-title":"Ital J Pediatr"},{"key":"2026030204312286400_ref5","article-title":"The impact of dysphagia in myositis: a systematic review and meta-analysis","volume":"9","author":"Labeit","journal-title":"J Clin Med Res"},{"key":"2026030204312286400_ref6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.5692\/clinicalneurol.cn-001863","article-title":"Two cases of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with severe diffuse subcutaneous oedema and dysphagia","volume":"63","author":"Takahashi","year":"2023","journal-title":"Rinsho Shinkeigaku: Clin Neurol"},{"key":"2026030204312286400_ref7","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003901","article-title":"Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody","volume":"10","author":"Fu","year":"2024","journal-title":"RMD Open"},{"key":"2026030204312286400_ref8","article-title":"Gastrointestinal involvement in dermatomyositis","volume":"12","author":"Matas","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2026030204312286400_ref9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12969-020-00486-x","article-title":"Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature","volume":"19","author":"Xu","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026030204312286400_ref10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00000441-200612000-00003","article-title":"Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association","volume":"332","author":"Tweezer-Zaks","year":"2006","journal-title":"Am J Med Sci"},{"key":"2026030204312286400_ref11","doi-asserted-by":"crossref","first-page":"e25771","DOI":"10.1097\/MD.0000000000025771","article-title":"Gastrointestinal perforation secondary to COVID-19 (Case Reports and Literature Review)","volume":"100","author":"Argan","year":"2021","journal-title":"Medicine"},{"key":"2026030204312286400_ref12","doi-asserted-by":"crossref","first-page":"107538","DOI":"10.1016\/j.ijscr.2022.107538","article-title":"COVID-19 infection and large intestinal perforation: a case series","volume":"98","author":"Masanam","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"2026030204312286400_ref13","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00384-020-03627-6","article-title":"Bowel perforation in a Covid-19 patient: case report","volume":"35","author":"Nardi","year":"2020","journal-title":"Int J Color Dis"},{"key":"2026030204312286400_ref14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/jpm10040157","article-title":"Spontaneous rectal perforation in a patient with SARS-CoV-2 infection","volume":"10","author":"Giuffr\u00e8","year":"2020","journal-title":"J Pers Med"},{"key":"2026030204312286400_ref15","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/acr.24879","article-title":"Gastrointestinal perforation in a patient with antinuclear matrix protein 2 antibody-positive dermatomyositis","volume":"74","author":"Valenzuela","year":"2022","journal-title":"Arthritis Care Res"},{"key":"2026030204312286400_ref16","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1111\/1756-185X.14755","article-title":"Anti-nuclear matrix protein 2 antibody-positive dermatomyositis with gastrointestinal ulcers: a case report","volume":"26","author":"Uchio","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"2026030204312286400_ref17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4253\/wjge.v16.i8.483","article-title":"Esophageal ulcer and multisystem inflammatory syndrome after COVID-19: a case report","volume":"16","author":"Yang","year":"2024","journal-title":"World J Gastrointest Endosc"},{"key":"2026030204312286400_ref18","first-page":"682","article-title":"A case of haemorrhagic myositis with concurrent anti-Ro52 and anti-NXP-2 antibodies treated with plasmapheresis","volume":"59","author":"Brown","year":"2020","journal-title":"Rheumatology"},{"key":"2026030204312286400_ref19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/pch\/pxx209","article-title":"A 17-year-old girl with facial edema and weakness","volume":"23","author":"Deschamps","year":"2015","journal-title":"Paediatr Child Health"},{"key":"2026030204312286400_ref20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12969-023-00893-w","article-title":"Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature","volume":"21","author":"Chang","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026030204312286400_ref21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/mrcr\/rxac086","article-title":"Hepatic veno-occlusive disease accompanied by thrombotic microangiopathy developed during treatment of juvenile dermatomyositis and macrophage activation syndrome: a case report","volume":"7","author":"Mouri","year":"2023","journal-title":"Mod Rheumatol Case Rep"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxag012\/66798650\/rxag012.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag012\/66798650\/rxag012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag012\/66798650\/rxag012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:31:32Z","timestamp":1772443892000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxag012\/8466337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxag012","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rxag012"}}